NCT05849818

Brief Summary

The purpose of the study is to identify the effect of fully-immersive virtual reality technology on cognitive functions of children with Down syndrome

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 14, 2023

Completed
17 days until next milestone

Study Start

First participant enrolled

May 1, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 9, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2023

Completed
Last Updated

May 9, 2023

Status Verified

April 1, 2023

Enrollment Period

2 months

First QC Date

April 14, 2023

Last Update Submit

April 28, 2023

Conditions

Keywords

Down syndrome DSVirtual Reality VR

Outcome Measures

Primary Outcomes (1)

  • Rate of change of cognitive function by using the rehacom device

    Assessing the change of the cognitive function By using the Rehacom Device within two months

    up to two months

Study Arms (2)

Effect of fully immersive VR + school regular activities on cognitive functions of Down children

EXPERIMENTAL

Children in this group will practice the same activities as control group in addition to virtual reality session using fully-immersive VRapeutic software gaming technology (Viblio module)for 20 min/3sessions/week for 8 weeks.

Device: full-immersive VRapeutic software gaming technology

Effect of school regular activities on cognitive functions of down children

NO INTERVENTION

Children in this group will practice their regular activities of school and daily living (receive no treatment).

Interventions

* Children of the study group will receive VR training sessions 3 times per week for 8 successive weeks. * Viblio VRapeutic fully immersive game will be used. * Manual instructions of the game will be followed and features of the game will be customized. * The child instructed to put back a pile of books on the floor into their shelves. * Level II of the game we will use audio visual distractors , repeated parrot sound and the child is required to order the books by colors * Level III distracting tasks during book ordering * The complexity of the game depend on task duration, number of books and the nature of distractors

Also known as: VRapeutic software gaming technology
Effect of fully immersive VR + school regular activities on cognitive functions of Down children

Eligibility Criteria

Age6 Years - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Diagnosed with Down Syndrome Age from 6-10 years Both Genders will be included IQ Ranges from 50-69(mild intellectual disability) they will be able to understand the instructions able to walk independently

You may not qualify if:

  • Significant Visual or Hearing problems Significant mental or psychological problems that interfere with understanding instructions musculoskeletal problems or fixed deformities in upper or lower limbs Current hospitalization for urgent Medical reasons

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo University

Giza, 12511, Egypt

RECRUITING

MeSH Terms

Conditions

Down Syndrome

Condition Hierarchy (Ancestors)

Intellectual DisabilityNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesAbnormalities, MultipleCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesChromosome DisordersGenetic Diseases, Inborn

Study Officials

  • Amira Eltohamy, professor

    Cairo University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Amira Eltohamy, Professor

CONTACT

maya galal, lecturer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A prospective Randomized controlled trial of pre-post study design with a two months follow up evaluation will be used
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Pediatric physical therapy

Study Record Dates

First Submitted

April 14, 2023

First Posted

May 9, 2023

Study Start

May 1, 2023

Primary Completion

July 1, 2023

Study Completion

August 1, 2023

Last Updated

May 9, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations